CLINICAL SCIENCE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2025-04-17 ms4000001421178858 来自上海

在哪里看投稿状态呀，投稿网站看不到，也没有邮件

38 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2021-02-28 12362864m67暂无昵称

稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急

160 8 举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2024-07-10 ms2000001536842427 来自云南省

manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的

84 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2024-12-25 yubeiqin 来自上海

求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？

62 16 举报

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2024-11-30 发sci发发发来自江苏省

偏重的研究方向：动物实验;基础实验
经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀

29 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2020-12-01 ygbn2003

审稿速度:2.0 | 投稿命中率:25.0
经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊

194 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2024-03-15 Stou18389577351 来自广西

偏重的研究方向：肿瘤
经验分享：周期四个月左右可以踢

85 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2021-07-02 12362864m67暂无昵称

审稿速度:2.0 | 投稿命中率:25.0
经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。

167 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2022-12-14 水逆退散～来自广西

偏重的研究方向：临床结合基础研究
经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思

117 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260836, encodeId=8a472260836d0, content=在哪里看投稿状态呀，投稿网站看不到，也没有邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a885562914, createdName=ms4000001421178858, createdTime=Thu Apr 17 13:51:03 CST 2025, time=2025-04-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=944268, encodeId=a40894426863, content=稿件号0076，under peer review40天了还没消息，有必要催一下不，好捉急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Sun Feb 28 20:51:46 CST 2021, time=2021-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2214325, encodeId=cf75221432544, content=manuscript rejected后又in review是什么意思啊，是不是拒了，要不要撤稿重复投其他的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ad05653587, createdName=ms2000001536842427, createdTime=Wed Jul 10 22:27:37 CST 2024, time=2024-07-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2244794, encodeId=df662244e9451, content=求教：通过Kriyadocs系统投的稿，为什么系统里边啥都没有？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db982710937, createdName=yubeiqin, createdTime=Wed Dec 25 12:08:55 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2240033, encodeId=88a52240033c1, content=偏重的研究方向：动物实验;基础实验 经验分享：有没有投过的好心人分享一下每个流程的周期呀，看官网说提交到第一次决定需要39天，谢谢呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ac5308712, createdName=发sci发发发, createdTime=Sat Nov 30 11:27:42 CST 2024, time=2024-11-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=903765, encodeId=fab8903e6588, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Current Stage: In review，具体的stage: manuscript rejected，然后紧接着是in review，under peer revie一共50天，邮件目前还没发来，我想看看具体意见，一般要等几天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10831618640, createdName=ygbn2003, createdTime=Tue Dec 01 09:15:47 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193434, encodeId=e8312193434ee, content=偏重的研究方向：肿瘤 经验分享：周期四个月左右可以踢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/21497983ee504933a98597291fbf6bc5-ZZP4hn6SBnAE.jpg, createdBy=6beb9211769, createdName=Stou18389577351, createdTime=Fri Mar 15 16:43:37 CST 2024, time=2024-03-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=979002, encodeId=2c789e9002f2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：前后经历拒稿重投，一审大修，一共160天，刚接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202410/bbb66531d9a74ae0a78ee9bcda937588-Y4lHpEqJnxCi.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Fri Jul 02 13:54:12 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106011, encodeId=6ca72106011ad, content=偏重的研究方向：临床结合基础研究 经验分享： Under peer review两个月以后decision pending然后变成 in review是啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210506/03e641e496f246868d0a685a1c4c9c9c/400a16594e81429fa2005190467547ef.jpg, createdBy=9c375406070, createdName=水逆退散～, createdTime=Wed Dec 14 14:36:16 CST 2022, time=2022-12-14, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1234853, encodeId=799b12348537c, content=投稿命中率:50.0 偏重的研究方向：肺损伤;脓毒症 经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。 7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8676569935, createdName=ms4000001384593752, createdTime=Tue Jul 26 12:27:55 CST 2022, time=2022-07-26, status=1, ipAttribution=)]

2022-07-26 ms4000001384593752

投稿命中率:50.0
偏重的研究方向：肺损伤;脓毒症
经验分享：7月1号submit，过了3天说图片像素不够，要附上WB原始图。
7月5号改好重新submit。几天后拒稿了。没说原因就说不合适。

119 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务